Tonix Pharmaceuticals Holding Corp Asset Turnover Ratio (TNXP), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tonix Pharmaceuticals Holding Corp   (NASDAQ: TNXP)
 

Tonix Pharmaceuticals Holding Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Tonix Pharmaceuticals Holding Corp asset turnover ratio, the ability of Tonix Pharmaceuticals Holding Corp 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.17 in the third quarter (Sep 30 2026), TNXP's balance sheet remain strong.

Within sector 157 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 3362, from total ranking in the second quarter 2026 at 4011.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TNXP Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -4.12 % 35.62 % 33.72 % 65.48 % 165.76 %
Y / Y Revenue Change 423.83 % 577.88 % 183.16 % 108.75 % 16.58 %
Asset Turnover Ratio (TTM) 0.17 0.11 0.07 0.06 0.05
TNXP's Total Ranking # 3362 # 4011 # 3518 # 3531 # 3526
Seq. Asset Change -4.74 % -1.48 % -6.95 % 9.8 % 34.74 %
Seq. Revenue Change 27.24 % 96.92 % 27.61 % 63.83 % 64.66 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 472
Overall Market # 3362

Asset Turnover Ratio Statistics
High Average Low
0.11 0.08 0.05
(Jun 30 2026)   (Sep 30 2025)




TNXP Company Profile • Back to TNXP Efficiency Comparisons • Compare TNXP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Syndax Pharmaceuticals Inc   0.48 $ 289.431  Millions$ 599.674  Millions
Abbvie Inc   0.48 $ 66,014.000  Millions$ 138,304.500  Millions
Zevra Therapeutics Inc   0.48 $ 140.548  Millions$ 294.899  Millions
Boston Scientific Corporation  0.47 $ 21,070.000  Millions$ 44,675.250  Millions
Organon and Co   0.47 $ 6,111.000  Millions$ 13,110.500  Millions
Clearpoint Neuro Inc   0.47 $ 45.493  Millions$ 97.658  Millions
Abbott Laboratories  0.47 $ 48,229.000  Millions$ 103,651.000  Millions
Integra Lifesciences Holdings Corp  0.47 $ 1,656.786  Millions$ 3,562.754  Millions
Vertex Pharmaceuticals Inc  0.46 $ 12,951.600  Millions$ 28,071.750  Millions
Pacific Health Care Organization Inc  0.46 $ 6.368  Millions$ 13.927  Millions
Alkermes Plc   0.45 $ 1,753.599  Millions$ 3,893.429  Millions
Verastem Inc   0.44 $ 100.296  Millions$ 227.600  Millions
Bausch Health Companies Inc   0.44 $ 11,113.000  Millions$ 25,285.500  Millions
Ars Pharmaceuticals Inc   0.44 $ 122.136  Millions$ 279.051  Millions
Butterfly Network Inc   0.43 $ 123.715  Millions$ 288.356  Millions
Lemaitre Vascular Inc   0.42 $ 269.938  Millions$ 635.449  Millions
Aurinia Pharmaceuticals Inc   0.42 $ 321.738  Millions$ 773.387  Millions
Arvinas Inc   0.42 $ 275.300  Millions$ 662.000  Millions
Amgen Inc   0.42 $ 38,903.000  Millions$ 93,694.250  Millions
Novavax inc   0.41 $ 411.649  Millions$ 1,015.814  Millions
Jazz Pharmaceuticals Plc  0.41 $ 4,718.126  Millions$ 11,649.385  Millions
Iovance Biotherapeutics inc   0.40 $ 378.983  Millions$ 936.395  Millions
Zai Lab Limited  0.40 $ 441.727  Millions$ 1,091.702  Millions
Regeneron Pharmaceuticals Inc   0.40 $ 16,896.200  Millions$ 41,890.825  Millions
Bausch and Lomb Corp  0.39 $ 5,418.000  Millions$ 13,905.000  Millions
Ptc Therapeutics inc   0.38 $ 1,155.554  Millions$ 3,056.516  Millions
Regenxbio Inc   0.37 $ 153.911  Millions$ 411.896  Millions
Beta Bionics Inc   0.37 $ 127.899  Millions$ 342.326  Millions
Rxsight Inc   0.37 $ 122.088  Millions$ 327.231  Millions
Sotera Health Company  0.37 $ 1,230.250  Millions$ 3,298.320  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.